Human milk pasteurization: benefits and risks.
Deborah L O'Connor, Julia B Ewaschuk, Sharon Unger
https://pubmed.ncbi.nlm.nih.gov/25769062/Actively Recruiting
Led by Columbia University · Updated on 2026-04-07
50
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether targeted fortification of donor breast milk improves growth in preterm infants compared to standard fortification. The study focuses on premature infants born at or before 30 weeks gestational age with low birth weight. Donor breast milk often has less nutrition than mothers milk, so the study aims to determine if customizing added nutrients based on measured milk content benefits infant growth. The trial compares two groups one receiving standard fortification of donor milk and the other receiving targeted fortification based on measured fat, protein, and carbohydrate levels using a human milk analyzer. Targeted fortification adjusts nutrient additions daily to reach specific protein, fat, and carbohydrate goals. Both groups receive mothers milk when available, fortified in the standard way. Additional supplements may be added if poor growth occurs. Participants are followed until they reach 34 weeks corrected gestational age. During the study, infants weight, length, and head circumference are measured for up to 11 weeks. Researchers also monitor hospital stay length, mortality, feeding intolerance, necrotizing enterocolitis, bronchopulmonary dysplasia, retinopathy of prematurity, and feeding types up to one year. Milk batches are analyzed for nutrient content. The study provides detailed monitoring of growth and health outcomes while infants receive their assigned milk fortification.
CONDITIONS
Targeted Fortification of Donor Breast Milk in Preterm Infants
M
Marianne Garland, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Columbia University
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Individualized Targeted Fortification | Standard Fortification Protocol |
|---|---|---|
| What it is | Customizes the added fortifiers to donor or mother's milk for each infant based on macronutrient analysis of individual milk batches. | Uses a fixed amount of Similac Human Milk Fortifier for donor or mother's milk in all infants, with extra fortification only added if growth is insufficient. |
| Role in the trial | Investigational method to determine if individualized nutrition improves preterm infant growth outcomes compared to standard methods. | Comparator arm using the conventional NICU protocol for breast milk fortification in preterm infants. |
| Primary use or purpose | Aims to optimize growth and nutrition by personalizing the composition of milk fortification for each preterm infant. | Routinely used to supplement protein, fat, and carbohydrate in breast milk for preterm infants to support growth. |
| How it is given or performed | Milk from each batch is analyzed for macronutrient content using the Miris Human Milk Analyzer. The results determine specific amounts of protein, fat, or carbohydrate fortifier to add to reach preset nutrition targets. | A fixed number of packs of fortifier is added per set volume of donor or mother's milk. Additional fortifiers (protein, fat, carbohydrate) may be introduced only if ongoing growth is insufficient, based on standard NICU procedures. |
| Evidence status | Clinical studies suggest individualized fortification may improve growth and protein intake for preterm infants versus standard methods, but evidence is still emerging and further randomized data are needed. | Well established as a baseline for preterm infant nutrition, but a portion of infants may experience suboptimal growth, motivating further optimization strategies. |
| Important limitations | Requires access to specialized milk analysis technology and experienced clinical staff; cost and workflow may limit routine use. Clinical benefit over standard fortification is not yet certain for all relevant outcomes. | Does not account for substantial batch-to-batch and donor-to-donor variability of macronutrient contents in human milk, risking under- or over-fortification for individual infants. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Until 34 weeks corrected gestational age
Participants receive either standard fortified breast milk or targeted fortified donor breast milk with additional nutritional fortifiers customized based on milk analysis to support infant growth.
Daily feeding and fortification with regular milk analysis
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Deborah L O'Connor, Julia B Ewaschuk, Sharon Unger
https://pubmed.ncbi.nlm.nih.gov/25769062/Gerhard Fusch, Niels Rochow, Arum Choi...
https://pubmed.ncbi.nlm.nih.gov/24912866/Niels Rochow, Gerhard Fusch, Arum Choi...
https://pubmed.ncbi.nlm.nih.gov/23769498/Hélène Billard, Laure Simon, Emmanuelle Desnots...
https://pubmed.ncbi.nlm.nih.gov/26037506/Meiying Quan, Danhua Wang, Lijuan Gou...
https://pubmed.ncbi.nlm.nih.gov/31268194/Christoph Fusch
https://pubmed.ncbi.nlm.nih.gov/30985203/Laura Morlacchi, Domenica Mallardi, Maria Lorella Giannì...
https://pubmed.ncbi.nlm.nih.gov/27370649/Sertac Arslanoglu, Clair-Yves Boquien, Caroline King...
https://pubmed.ncbi.nlm.nih.gov/30968003/N Montjaux-Régis, C Cristini, C Arnaud...
https://pubmed.ncbi.nlm.nih.gov/21707744/Ashley John, Ruichen Sun, Lisa Maillart...
https://pubmed.ncbi.nlm.nih.gov/30682200/Columbia University
Lead Sponsor